What is regulatory policy and why does it matter for plasma-derived medicines and rare diseases? It’s about ensuring treatments are safe, effective, and get to the patients who need them most. Watch as PPTA’s James Knowles, Senior Director, Global Regulatory Policy, breaks it down in this short video.